These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France. Fournier A; Zureik M Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872 [TBL] [Abstract][Full Text] [Related]
17. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage. Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435 [No Abstract] [Full Text] [Related]
18. How can benfluorex-related heart valve disease be identified by echocardiography? Tribouilloy C; Rusinaru D; Andréjak M Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700 [No Abstract] [Full Text] [Related]
19. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study. Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218 [TBL] [Abstract][Full Text] [Related]
20. Clinical and echographic characteristics of patients exposed to fenfluramin or its derivatives: Results of a prospective, single-centre, observational study. Cambon D; Leclercq F Arch Cardiovasc Dis; 2015 Mar; 108(3):172-80. PubMed ID: 25754908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]